Skip to main content
Top
Published in: Journal of Cancer Survivorship 3/2012

01-09-2012

Patient perceptions of reproductive health counseling at the time of cancer diagnosis: a qualitative study of female California cancer survivors

Authors: Erin Ebbel Niemasik, Joseph Letourneau, Daniel Dohan, Audra Katz, Michelle Melisko, Hope Rugo, Mitchell Rosen

Published in: Journal of Cancer Survivorship | Issue 3/2012

Login to get access

Abstract

Purpose

We sought to determine what women recall about reproductive health risks (RHR) from cancer therapy at the time of cancer diagnosis in order to identify barriers to reproductive health counseling (RHC) and fertility preservation (FP).

Methods

Data were obtained by surveying 1,041 female cancer survivors from the California Cancer Registry. Inclusion criteria included women age 18–40 with a diagnosis of leukemia, Hodgkin’s disease, non-Hodgkin’s lymphoma, breast or GI cancer diagnosed between 1993 and 2007. Women were asked to respond to an open-ended question: “what did your doctor tell you about how cancer treatment could affect your ability to get pregnant?” Framework analysis was used to identify themes surrounding patient perceptions of RHC.

Results

Of the patients, 51.8 % (361 out of 697) recalled receiving reproductive health counseling and 12.2 % (85 out of 697) recalled receiving FP counseling. Of the patients, 45.3 % (277 out of 612) reported that uncertain prognosis, risk of recurrence or vertical transmission, age, parity, or uncertain desire may have prevented them from receiving timely and essential information on RHRs. Communication barriers included omission of information, failure to disclose RHRs, and presentation of incorrect information on FP.

Discussion

In a sample of women diagnosed with cancer of reproductive age, almost half did not recall counseling on RHRs and few recalled FP counseling. Communication barriers between physicians and patients regarding fertility may lead to uninformed (reproductive health) RH decisions.

Implications for cancer survivors

Many women may not receive adequate information about RHRs or FP at the time of cancer diagnosis. Advancements in reproductive technology and emerging organizations that cover financial costs of FP have dramatically changed what options women have to preserve their fertility. Routine and thoughtful RHR and FP counseling, as well as collaborative cancer care will help ensure that women diagnosed with cancer are provided with the services and information they need to make an informed choice about their reproductive future.
Appendix
Available only for authorised users
Literature
2.
go back to reference Schover LR. Patient attitudes toward fertility preservation. Pediatr Blood Cancer. 2009;53:281–4.PubMedCrossRef Schover LR. Patient attitudes toward fertility preservation. Pediatr Blood Cancer. 2009;53:281–4.PubMedCrossRef
3.
go back to reference Partridge AH, Gelber S, Peppercorn J, Sampson E, Knudsen K, Laufer M, et al. Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol. 2004;22:4174–83.PubMedCrossRef Partridge AH, Gelber S, Peppercorn J, Sampson E, Knudsen K, Laufer M, et al. Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol. 2004;22:4174–83.PubMedCrossRef
4.
go back to reference Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24:2917–31.PubMedCrossRef Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24:2917–31.PubMedCrossRef
5.
go back to reference Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in cancer patients. Fertil Steril. 2005;83:1622–8.CrossRef Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in cancer patients. Fertil Steril. 2005;83:1622–8.CrossRef
6.
go back to reference Schover LR, Rybicki LA, Martin BA, Bringelsen KA. Having children after cancer. A pilot survey of survivors’ attitudes and experiences. Cancer. 1999;86:697–709.PubMedCrossRef Schover LR, Rybicki LA, Martin BA, Bringelsen KA. Having children after cancer. A pilot survey of survivors’ attitudes and experiences. Cancer. 1999;86:697–709.PubMedCrossRef
7.
go back to reference Zebrack BJ, Casillas J, Nohn L, Adams H, Zeltzer LK. Fertility issues for young adult survivors of childhood cancer. Psychooncology. 2004;13:689–99.PubMedCrossRef Zebrack BJ, Casillas J, Nohn L, Adams H, Zeltzer LK. Fertility issues for young adult survivors of childhood cancer. Psychooncology. 2004;13:689–99.PubMedCrossRef
8.
go back to reference Jenninga E, Hilders CG, Louwe LA, Peters AA. Female fertility preservation: practical and ethical considerations of an underused procedure. Cancer. 2008;14:333–9.CrossRef Jenninga E, Hilders CG, Louwe LA, Peters AA. Female fertility preservation: practical and ethical considerations of an underused procedure. Cancer. 2008;14:333–9.CrossRef
9.
go back to reference Letourneau JM, Ebbel EE, Katz PP, Oktay KH, McCulloch CE, Ai WZ, et al. Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer. Cancer. 2011;118(7):1933–9.PubMedCrossRef Letourneau JM, Ebbel EE, Katz PP, Oktay KH, McCulloch CE, Ai WZ, et al. Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer. Cancer. 2011;118(7):1933–9.PubMedCrossRef
10.
go back to reference Loprinzi CL, Wolf SL, Barton DL, Laack NN. Symptom management in premenopausal patients with breast cancer. Lancet Oncol. 2008;9:993–1001.PubMedCrossRef Loprinzi CL, Wolf SL, Barton DL, Laack NN. Symptom management in premenopausal patients with breast cancer. Lancet Oncol. 2008;9:993–1001.PubMedCrossRef
11.
go back to reference Letourneau JM, Melisko ME, Cedars MI, Rosen MP. A changing perspective: improving access to fertility preservation. Nat Rev Clin Oncol. 2011;8:56–60.PubMedCrossRef Letourneau JM, Melisko ME, Cedars MI, Rosen MP. A changing perspective: improving access to fertility preservation. Nat Rev Clin Oncol. 2011;8:56–60.PubMedCrossRef
12.
go back to reference Quinn GP, Vadaparampil ST, Lee JH, Jacobsen PB, Bepler G, Lancaster J, et al. Physician referral for fertility preservation in oncology patients: a national study of practice behaviors. J Clin Oncol. 2009;27:5952–7.PubMedCrossRef Quinn GP, Vadaparampil ST, Lee JH, Jacobsen PB, Bepler G, Lancaster J, et al. Physician referral for fertility preservation in oncology patients: a national study of practice behaviors. J Clin Oncol. 2009;27:5952–7.PubMedCrossRef
13.
go back to reference Creswell JW. Qualitative inquiry & research design: choosing among five approaches. Thousand Oaks: Sage; 2007. Creswell JW. Qualitative inquiry & research design: choosing among five approaches. Thousand Oaks: Sage; 2007.
14.
go back to reference Srivastava A, Thomson SB. Framework analysis: a qualitative methodology for applied policy research. JOAAG. 2009;4(2):72–9. Srivastava A, Thomson SB. Framework analysis: a qualitative methodology for applied policy research. JOAAG. 2009;4(2):72–9.
15.
go back to reference Sandman L, Munthe C. Shared decision-making and patient autonomy. Theor Med Bioeth. 2009;30(4):289–310.PubMedCrossRef Sandman L, Munthe C. Shared decision-making and patient autonomy. Theor Med Bioeth. 2009;30(4):289–310.PubMedCrossRef
16.
go back to reference Elwyn G, Edwards A, Hood K, Robling M, Atwell C, Russell I, et al. Achieving involvement: process outcomes from a cluster randomized trial of shared decision making skill development and use of risk communication aids in general practice. Fam Pract. 2004;21(4):337–46.PubMedCrossRef Elwyn G, Edwards A, Hood K, Robling M, Atwell C, Russell I, et al. Achieving involvement: process outcomes from a cluster randomized trial of shared decision making skill development and use of risk communication aids in general practice. Fam Pract. 2004;21(4):337–46.PubMedCrossRef
17.
go back to reference Sandman L, Munthe C. Shared decision-making, paternalism and patient choice. Health Care Anal. 2010;18(1):60–84.PubMedCrossRef Sandman L, Munthe C. Shared decision-making, paternalism and patient choice. Health Care Anal. 2010;18(1):60–84.PubMedCrossRef
18.
go back to reference Tschudin S, Bitzer J. Psychological aspects of fertility preservation in men and women affected by cancer and other life threatening diseases. Hum Reprod Update. 2009;15:587–97.PubMedCrossRef Tschudin S, Bitzer J. Psychological aspects of fertility preservation in men and women affected by cancer and other life threatening diseases. Hum Reprod Update. 2009;15:587–97.PubMedCrossRef
19.
go back to reference Jeruss JS, Woodruff TK. Preservation of fertility in patients with cancer. N Engl J Med. 2009;360(9):902–11.PubMedCrossRef Jeruss JS, Woodruff TK. Preservation of fertility in patients with cancer. N Engl J Med. 2009;360(9):902–11.PubMedCrossRef
20.
go back to reference Penrose R, Beatty L, Mattiske J, Koczwara B. Fertility and cancer—a qualitative study of Australian cancer survivors. Support Care Cancer. 2011;20(6):1259–65.PubMedCrossRef Penrose R, Beatty L, Mattiske J, Koczwara B. Fertility and cancer—a qualitative study of Australian cancer survivors. Support Care Cancer. 2011;20(6):1259–65.PubMedCrossRef
21.
go back to reference Woodruff TK. The Oncofertility Consortium—addressing fertility in young people with cancer. Nat Rev Clin Oncol. 2010;7(8):466–75.PubMedCrossRef Woodruff TK. The Oncofertility Consortium—addressing fertility in young people with cancer. Nat Rev Clin Oncol. 2010;7(8):466–75.PubMedCrossRef
22.
go back to reference Patel A, Sreedevi M, Malapati R, Sutaria R, Schoenhage MB, Patal AR, et al. Reproductive health assessment for women with cancer: a pilot study. Am J Obstet Gynecol. 2009;201(2):191. e1–e4.PubMedCrossRef Patel A, Sreedevi M, Malapati R, Sutaria R, Schoenhage MB, Patal AR, et al. Reproductive health assessment for women with cancer: a pilot study. Am J Obstet Gynecol. 2009;201(2):191. e1–e4.PubMedCrossRef
23.
go back to reference Letourneau JM, Ebbel EE, Katz PP, Katz A, Ai WZ, Chien AJ, et al. Pre-treatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer. 2011;118(6):1710–7.PubMedCrossRef Letourneau JM, Ebbel EE, Katz PP, Katz A, Ai WZ, Chien AJ, et al. Pre-treatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer. 2011;118(6):1710–7.PubMedCrossRef
24.
go back to reference Wenzel L, Dogan-Ates A, Habbal R, Berkowitz R, Goldstein DP, Bernstein M, et al. Defining and measuring reproductive concerns of female cancer survivors. J Natl Cancer Inst Monogr. 2005;34:94–8.PubMedCrossRef Wenzel L, Dogan-Ates A, Habbal R, Berkowitz R, Goldstein DP, Bernstein M, et al. Defining and measuring reproductive concerns of female cancer survivors. J Natl Cancer Inst Monogr. 2005;34:94–8.PubMedCrossRef
25.
go back to reference Reh AE, Lu L, Weinerman R, Grifo J, Krey L, Noyes N. Treatment outcomes and quality-of-life assessment in a university-based fertility preservation program: results of a registry of female cancer patients at 2 years. J Assist Reprod Genet. 2011;28(7):635–41.PubMedCrossRef Reh AE, Lu L, Weinerman R, Grifo J, Krey L, Noyes N. Treatment outcomes and quality-of-life assessment in a university-based fertility preservation program: results of a registry of female cancer patients at 2 years. J Assist Reprod Genet. 2011;28(7):635–41.PubMedCrossRef
26.
go back to reference Ives A, Saunders C, Bulsara M, Semmens J. Pregnancy after breast cancer: population based study. BMJ. 2007;334:194–9.PubMedCrossRef Ives A, Saunders C, Bulsara M, Semmens J. Pregnancy after breast cancer: population based study. BMJ. 2007;334:194–9.PubMedCrossRef
27.
go back to reference Azim HA, Peccatori FA, de Azambuja E, Piccart MJ. Motherhood after breast cancer: searching for la dolce vita. Expert Rev Anticancer Ther. 2011;11(2):287–98.PubMedCrossRef Azim HA, Peccatori FA, de Azambuja E, Piccart MJ. Motherhood after breast cancer: searching for la dolce vita. Expert Rev Anticancer Ther. 2011;11(2):287–98.PubMedCrossRef
28.
go back to reference de Bree E, Makrigiannakis A, Askoxylakis J. Pregnancy after breast cancer: a comprehensive review. J Surg Oncol. 2010;101(6):534–42.PubMedCrossRef de Bree E, Makrigiannakis A, Askoxylakis J. Pregnancy after breast cancer: a comprehensive review. J Surg Oncol. 2010;101(6):534–42.PubMedCrossRef
29.
go back to reference Meuller BA, Simon MS, Deapen D, Kamineni A, Malone KE, Daling JR. Childbearing and survival after breast carcinoma in young women. Cancer. 2003;98(6):1131–40.CrossRef Meuller BA, Simon MS, Deapen D, Kamineni A, Malone KE, Daling JR. Childbearing and survival after breast carcinoma in young women. Cancer. 2003;98(6):1131–40.CrossRef
30.
go back to reference Sankila R, Heinavaara S, Hakulienen T. Survival of breast cancer patients after susbsequent term pregnancy “healthy mother effect”. Am J Obstet Gynecol. 1994;170:818–23.PubMed Sankila R, Heinavaara S, Hakulienen T. Survival of breast cancer patients after susbsequent term pregnancy “healthy mother effect”. Am J Obstet Gynecol. 1994;170:818–23.PubMed
31.
go back to reference Pagani O, Partridge A, Korde L, Badve S, Bartlett J, Albain K, et al. Pregnancy after breast cancer: if you wish, ma’am. Breast Cancer Res Treat. 2011;129:309–17.PubMedCrossRef Pagani O, Partridge A, Korde L, Badve S, Bartlett J, Albain K, et al. Pregnancy after breast cancer: if you wish, ma’am. Breast Cancer Res Treat. 2011;129:309–17.PubMedCrossRef
32.
go back to reference Blakely LJ, Buzdar AU, Lozada JA, Shullaih SA, Hoy E, Smith TL, et al. Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence. Cancer. 2004;100(3):465–9.PubMedCrossRef Blakely LJ, Buzdar AU, Lozada JA, Shullaih SA, Hoy E, Smith TL, et al. Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence. Cancer. 2004;100(3):465–9.PubMedCrossRef
33.
go back to reference Esserman LJ, Moore DH, Tsing PJ, Chu PW, Yau C, Ozanne E, et al. Biological markers determine both the risk and the timing of recurrence in breast cancer. Breast Cancer Res Treat. 2011;129:607–16.PubMedCrossRef Esserman LJ, Moore DH, Tsing PJ, Chu PW, Yau C, Ozanne E, et al. Biological markers determine both the risk and the timing of recurrence in breast cancer. Breast Cancer Res Treat. 2011;129:607–16.PubMedCrossRef
34.
go back to reference Langagergaard V, Gislum M, Skriver MV, Norgard B, Lash TL, Rothman KJ, et al. Birth outcome in women with breast cancer. Br J Cancer. 2006;94(1):142–6.PubMedCrossRef Langagergaard V, Gislum M, Skriver MV, Norgard B, Lash TL, Rothman KJ, et al. Birth outcome in women with breast cancer. Br J Cancer. 2006;94(1):142–6.PubMedCrossRef
35.
go back to reference Arnon J, Meirow D, Lewis-Roness H, Ornoy A. Genetic and teratogenic effects of cancer treatments on gametes and embryos. Hum Reprod Update. 2001;7(4):394–403.PubMedCrossRef Arnon J, Meirow D, Lewis-Roness H, Ornoy A. Genetic and teratogenic effects of cancer treatments on gametes and embryos. Hum Reprod Update. 2001;7(4):394–403.PubMedCrossRef
36.
go back to reference Meirow D, Epstein M, Lewis H, Nugent D, Gosden RG. Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations. Human Reprod. 2001;16(4):632–7.CrossRef Meirow D, Epstein M, Lewis H, Nugent D, Gosden RG. Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations. Human Reprod. 2001;16(4):632–7.CrossRef
37.
go back to reference Quinn GP, Vadaparampil ST, Tollin S, Miree CA, Murphy D, Bover B, et al. BRCA carriers’ thoughts on risk management in relation to preimplantation genetic diagnosis and childbearing: when too many choices are just as difficult as none. Fertil Steril. 2010;94(6):2473–5.PubMedCrossRef Quinn GP, Vadaparampil ST, Tollin S, Miree CA, Murphy D, Bover B, et al. BRCA carriers’ thoughts on risk management in relation to preimplantation genetic diagnosis and childbearing: when too many choices are just as difficult as none. Fertil Steril. 2010;94(6):2473–5.PubMedCrossRef
38.
go back to reference Quinn GP, Vadaparampil ST, Jacobsen PB, Knapp C, Keefe DL, Bell GE, et al. Frozen hope: fertility preservation for women with cancer. J Midwifery Womens Health. 2010;55:175–80.PubMedCrossRef Quinn GP, Vadaparampil ST, Jacobsen PB, Knapp C, Keefe DL, Bell GE, et al. Frozen hope: fertility preservation for women with cancer. J Midwifery Womens Health. 2010;55:175–80.PubMedCrossRef
39.
go back to reference Baruch S. Preimplantation genetic diagnosis and parental preferences: beyond deadly disease. House J Health Law Policy. 2008;8:245–70. Baruch S. Preimplantation genetic diagnosis and parental preferences: beyond deadly disease. House J Health Law Policy. 2008;8:245–70.
40.
go back to reference Simpson JL, Carson SA, Cisneros P. Preimplantation genetic diagnosis (PGD) for heritable neoplasis. J Natl Cancer Inst Monogr. 2005;3:87–90.CrossRef Simpson JL, Carson SA, Cisneros P. Preimplantation genetic diagnosis (PGD) for heritable neoplasis. J Natl Cancer Inst Monogr. 2005;3:87–90.CrossRef
41.
go back to reference Niermeijer MF, de Wert G, Dondorp W. Preimplantation genetic diagnosis for cancer. Lancet Oncol. 2006;7:794–5.PubMedCrossRef Niermeijer MF, de Wert G, Dondorp W. Preimplantation genetic diagnosis for cancer. Lancet Oncol. 2006;7:794–5.PubMedCrossRef
42.
go back to reference Quinn GP, Vadaparampil ST, Gwede CK, Miree C, King LM, Clayton HB, et al. Discussion of fertility preservation with newly diagnosed patients; oncologist’s views. J Cancer Surviv. 2007;1(2):146–55.PubMedCrossRef Quinn GP, Vadaparampil ST, Gwede CK, Miree C, King LM, Clayton HB, et al. Discussion of fertility preservation with newly diagnosed patients; oncologist’s views. J Cancer Surviv. 2007;1(2):146–55.PubMedCrossRef
43.
go back to reference Nakayama K, Liu P, Detry M, Schover LR, Milbourne A, Neumann J, et al. Receiving information on fertility-and menopause- related treatment effects among women who undergo hematopoietic stem cell transplanation: changes in perceived importance over time. Biol Blood Marrow Transplant. 2009;15:1465–74.PubMedCrossRef Nakayama K, Liu P, Detry M, Schover LR, Milbourne A, Neumann J, et al. Receiving information on fertility-and menopause- related treatment effects among women who undergo hematopoietic stem cell transplanation: changes in perceived importance over time. Biol Blood Marrow Transplant. 2009;15:1465–74.PubMedCrossRef
44.
go back to reference Huyghe E, Sui D, Odensky E, Schover LR. Needs assessment survey to justify establishing a reproductive health clinic at a comprehensive cancer center. J Sex Med. 2009;6:149–63.PubMedCrossRef Huyghe E, Sui D, Odensky E, Schover LR. Needs assessment survey to justify establishing a reproductive health clinic at a comprehensive cancer center. J Sex Med. 2009;6:149–63.PubMedCrossRef
45.
go back to reference Arora NK, Hamilton AS, Potosky AL, Rowland JH, Aziz NM, Bellizzi KM, et al. Population-based survivorship research using cancer registries: a study of non-Hodkin’s lymphoma survivors. J Cancer Surviv. 2007;1:49–63.PubMedCrossRef Arora NK, Hamilton AS, Potosky AL, Rowland JH, Aziz NM, Bellizzi KM, et al. Population-based survivorship research using cancer registries: a study of non-Hodkin’s lymphoma survivors. J Cancer Surviv. 2007;1:49–63.PubMedCrossRef
Metadata
Title
Patient perceptions of reproductive health counseling at the time of cancer diagnosis: a qualitative study of female California cancer survivors
Authors
Erin Ebbel Niemasik
Joseph Letourneau
Daniel Dohan
Audra Katz
Michelle Melisko
Hope Rugo
Mitchell Rosen
Publication date
01-09-2012
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 3/2012
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-012-0227-9

Other articles of this Issue 3/2012

Journal of Cancer Survivorship 3/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine